Form D Raw Data - Electronic Filing Depository

EFDID: 231970EFD: Raw Data

Issuer: Applied Therapeutics Inc. (0001697532) - D

Accession: 0000914760-17-000017 () (EDGAR Files) (Form D)

Edgar Posted: Feb. 8, 2017
EFD Posted: Feb. 8, 2017

- < edgarSubmission >

< schemaVersion > X0707 </ schemaVersion >

< submissionType > D </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001697532 </ cik >

< entityName > Applied Therapeutics Inc. </ entityName >

- < issuerAddress >

< street1 > 340 MADISON AVENUE </ street1 >

< street2 > 19TH FLOOR </ street2 >

< city > NEW YORK </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10173 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 212-220-9319 </ issuerPhoneNumber >

< jurisdictionOfInc > DELAWARE </ jurisdictionOfInc >

- < issuerPreviousNameList >

< value > None </ value >

</ issuerPreviousNameList >

- < edgarPreviousNameList >

< value > None </ value >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< withinFiveYears > true </ withinFiveYears >

< value > 2016 </ value >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Shoshana </ firstName >

< lastName > Shendelman </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > c/o Applied Therapeutics, Inc. </ street1 >

< street2 > 340 Madison Avenue, 19th Floor </ street2 >

< city > New York </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10173 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Les </ firstName >

< lastName > Funtleyder </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > c/o Applied Therapeutics, Inc. </ street1 >

< street2 > 340 Madison Avenue, 19th Floor </ street2 >

< city > New York </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10173 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Other Health Care </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > Decline to Disclose </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06b </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > false </ isAmendment >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2017-01-26 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isEquityType > true </ isEquityType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 0 </ minimumInvestmentAccepted >

- < salesCompensationList >

- < recipient >

< recipientName > Brookline Capital Market </ recipientName >

< recipientCRDNumber > 120852 </ recipientCRDNumber >

< associatedBDName > a division of CIM Securities, LLC </ associatedBDName >

< associatedBDCRDNumber > 120852 </ associatedBDCRDNumber >

- < recipientAddress >

< street1 > 509 MADISON AVENUE </ street1 >

< street2 > SUITE 1006 </ street2 >

< city > NEW YORK </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10022 </ zipCode >

</ recipientAddress >

- < statesOfSolicitationList >

< state > AL </ state >

< description > ALABAMA </ description >

< state > CA </ state >

< description > CALIFORNIA </ description >

< state > CO </ state >

< description > COLORADO </ description >

< state > CT </ state >

< description > CONNECTICUT </ description >

< state > FL </ state >

< description > FLORIDA </ description >

< state > IL </ state >

< description > ILLINOIS </ description >

< state > MI </ state >

< description > MICHIGAN </ description >

< state > MS </ state >

< description > MISSISSIPPI </ description >

< state > NJ </ state >

< description > NEW JERSEY </ description >

< state > NY </ state >

< description > NEW YORK </ description >

< state > TX </ state >

< description > TEXAS </ description >

< state > WI </ state >

< description > WISCONSIN </ description >

< state > WY </ state >

< description > WYOMING </ description >

</ statesOfSolicitationList >

< foreignSolicitation > false </ foreignSolicitation >

</ recipient >

</ salesCompensationList >

- < offeringSalesAmounts >

< totalOfferingAmount > 7000000 </ totalOfferingAmount >

< totalAmountSold > 6067875 </ totalAmountSold >

< totalRemaining > 932125 </ totalRemaining >

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 26 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 560000 </ dollarAmount >

< isEstimate > true </ isEstimate >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

</ findersFees >

< clarificationOfResponse > $490,000 reflects the cash sales commission to a broker and $70,000 reflects the value of the discount the broker receives when purchasing shares. </ clarificationOfResponse >

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

</ grossProceedsUsed >

< clarificationOfResponse > Other than the payment of salaries and other compensation and benefits in the ordinary course, no persons required to be named as executive officers, directors or promoters in response to Item 3 will receive any payment from the proceeds of this offering. </ clarificationOfResponse >

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > Applied Therapeutics Inc. </ issuerName >

< signatureName > /s/ Shoshana Shendelman </ signatureName >

< nameOfSigner > Shoshana Shendelman </ nameOfSigner >

< signatureTitle > President and Secretary </ signatureTitle >

< signatureDate > 2017-02-08 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >